CD8A and neoplasm: However, when combined with oncolytic vaccinia virus (OVV), erastin promotes therapeutic effectiveness and anti-tumor immunity by increasing the number of activated DCs and promoting the activity of tumor-specific CD8+T cells in the tumor (102).